Clinical Trials List
2022-09-15 - 2026-09-30
Phase III
Recruiting6
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ching-Shan Luo Division of Thoracic Medicine
- YUN-KAI YEH 無
- JING-QUAN ZHENG Division of General Internal Medicine
- Po-Hao Feng Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Hung Luo Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- Heng-Sheng Chao 未分科
- 趙恒勝 Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- 許志堅 Division of Ophthalmology
- YEN-HAN TSENG Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Hung Chen Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- Ching-His Siao Division of Ophthalmology
- 林定佑 Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- 陳宏吉 Division of Ophthalmology
- 邱立忠 Division of Thoracic Medicine
- Wen-Cheng Chang Division of Hematology & Oncology
- 枋岳甫 Division of Infectious Disease
- 黃宗楨 Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HSIANG HUANG Division of Thoracic Medicine
- 李柏昕 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- 溫岳峰 Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- 于鎧綸 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林建良 Division of Thoracic Medicine
- 蕭聖諺 Division of Thoracic Medicine
- Shang-Wen Chen Division of Thoracic Medicine
- 高婉真 Division of Thoracic Medicine
- 曹朝榮 Division of Thoracic Medicine
- 林正耀 Division of Thoracic Medicine
- 陳冠宇 Division of Thoracic Medicine
- 黃文聰 Division of Thoracic Medicine
- 陳彥勳 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
48 participants
-
Global
1000 participants
